Dr. Oz urges senators to reject Budd hemp amendment
The vote gives Congress until December to set hemp rules as industry groups and White House officials warn the ban would disrupt medical access and a $200 million market.
- On Saturday, the Senate killed Sen. Ted Budd's amendment to remove a temporary hemp ban delay in a 61-32 vote, following an appeal from Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz to reject the measure.
- Budd argued in a Wednesday floor speech that hemp products create a "public health crisis" that threatens children, harms the workforce, and undermines military readiness.
- Oz warned that passing the amendment would "undo significant gains" toward clinical approvals for hemp-derived CBD products relied on by Medicare beneficiaries, emphasizing the agency's commitment to these treatments.
- After defeating the amendment, the Senate passed the underlying continuing resolution in a 90-6 vote, preserving language led by Sen. Amy Klobuchar that delays the federal prohibition.
- Congress must now craft a long-term regulatory framework before November 12, when a nationwide restriction on hemp products takes effect, as the current provision only provides temporary relief.
9 Articles
9 Articles
The Derrick
Klobuchar, Senate make midnight move to end hemp ban
In the early morning hours of Saturday, the U.S. Senate passed a budget with a provision, led by Sen. Amy Klobuchar, to temporarily delay a nationwide hemp ban that has alarmed Minnesota’s booming industry of home-grown hemp products and THC…
Dr. Oz urges senators to reject Budd hemp amendment
Dr. Mehmet Oz, the administrator of the Centers for Medicare and Medicaid Services (CMS), is urging senators to not support an amendment that would allow a federal ban on most hemp-derived products to take effect in November. In a Friday letter, Oz noted he had “grave concerns” about the amendment from Sen. Ted Budd (R-N.C.),…
Dr. Oz Asks Senators To Delay Hemp Product Ban So Seniors Can Get CBD Products Covered Through Medicare - Marijuana Moment
Dr. Mehmet Oz, who leads the Centers for Medicare and Medicaid Services (CMS), is asking U.S. senators to reject an amendment that would keep a forthcoming ban on hemp products on track to take effect in November. “Passage of this amendment would undo significant gains that have been made to make clinically-appropriate full-spectrum hemp-derived CBD […]
Senate Votes To Delay Hemp Ban, Giving Lawmakers More Time To Craft Regulations To Keep THC Products Legal
The U.S. Senate has rejected an amendment to make sure that hemp THC products are federally recriminalized on time under a current plan that is set to go into effect in November, instead allowing a provision that would delay the ban to advance. Industry supporters say the move will hopefully give them more time to convince Congress to craft regulations as an alternative to prohibition. The anti-hemp proposal, from Sen. Ted Budd (R-NC) and severa…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
